3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Classical hematology
1
Conditions
Sarcopenia
1
Prediabetic State
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Peripheral Nervous System Diseases
1
Myelodysplastic Syndromes
1
Leukemia, Myeloid
1
Hematologic Neoplasms
1
Anemia, Aplastic
1
Interventions
maltodextrin
2
Resistance Training
2
Exercise
2
pembrolizumab
1
nicotinamide-beta-riboside
1
durvalumab
1
atezolizumab
1
Wearable Electronic Devices
1
Standard of Care
1
Relaxation Therapy
1
Nutrition Therapy
1
Nutrition Assessment
1
Nivolumab
1
Immune Checkpoint Inhibitors
1
Glutamine
1
Gloves, Surgical
1
Geriatric Assessment
1
Creatine
1
Chemotherapy, Adjuvant
1
Carboplatin
1
Caloric Restriction
1
CP protocol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcopenia
×
nicotinamide-beta-riboside
×
1 year
×
Clear all
NCT05194397
2025-12-04
IAMFIT
Children's Hospital of Philadelphia
Phase 2
Recruiting
80 enrolled